Recall Alert: Xanax Recalled Nationwide
- On April 15, Viatris, Inc. initiated a nationwide Class II recall for lot 8177156 of 3mg Xanax XR tablets after the medication failed dissolution specifications.
- The FDA classified the action as a Class II recall, meaning tablets may not dissolve at the intended rate and could cause temporary, reversible health effects.
- Separately, a 'looksmaxxing' influencer was hospitalized after a suspected overdose during a livestream, and a fire at Boston Medical Center forced an early Wednesday evacuation.
- Patients prescribed the affected medication should stop taking it and safely dispose of it, while pharmacies return stock to Viatris.
- Approximately 3.6 million Americans take Xanax, though the recall affects only one lot distributed through May 2025, leaving other batches and generics unaffected.
25 Articles
25 Articles
Batch of Anti-Anxiety Drug Xanax Recalled Over Safety Concerns
A single lot of a widely used anti-anxiety drug called Xanax has been recalled, the U.S. Food and Drug Administration (FDA) announced. The post Batch of Widely Used Anti-Anxiety Drug Xanax Recalled Over Safety Concerns appeared first on Breitbart.
FDA Issues Notice of Nationwide Recall of Common Anxiety Medication
The maker of Xanax is recalling a batch of the widely prescribed anxiety medication across the United States, according to a notice published by the Food and Drug Administration (FDA). U.S.-based pharmaceutical company Viatris Inc. is recalling Xanax, or alprazolam, because it failed to meet dissolution specifications, says the FDA report uploaded to its website this week. That means that a drug may not be able to deliver the correct dosage over…
Coverage Details
Bias Distribution
- 58% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
















